Document:

<PAGE>   1

                                                                    EXHIBIT 10.9

                               GUARANTY AGREEMENT

        In this agreement "Guarantor" refers to each person, partnership,
corporation, limited liability company, association or legal entity which signs
this agreement. "Bank" refers to Bank of America, N.A., its successor and
assigns.

        1. GUARANTOR'S PROMISE TO REIMBURSE BANK FOR BORROWER'S OBLIGATION TO
BANK. To induce Bank to lend money, or extend other credit to Illuminet, Inc., a
Delaware corporation ("Borrower"), or for other consideration, Guarantor
guarantees payment to Bank of all the Obligations. "Obligations" means all
principal, interest, late charges, loan fees, collection costs and expenses,
attorneys' fees and legal expenses (including the allocated cost of in-house
counsel, and including all legal fees incurred in any action, bankruptcy
proceeding, arbitration or other alternative dispute resolution proceeding, or
appeal, or in the course of exercising any judicial or nonjudicial remedies)
which Borrower may now owe to Bank or for which Borrower may become obligated to
pay or reimburse Bank for in the future arising out of the Revolving Note and
the Converting Note each dated May 9, 2000, made by Borrower in the maximum
principal amounts of $10,000,000 and $15,000,000 respectively, including all
renewals, modifications, and extensions thereof, and shall also mean all
"Obligations" as such term is defined in the Credit Agreement dated as of May 9,
2000, between Borrower and Bank, including all amendments thereto and
restatements thereof.

        2. BENEFIT FROM GUARANTOR'S PROMISE. Guarantor is either financially
interested in Borrower or will receive other benefits, directly or indirectly,
as a result of Guarantor's promise.

        3. BANK'S RIGHT NOT TO PROCEED AGAINST BORROWER OR OTHERS. Guarantors
promise is joint and several as to each of the individuals or entities signing
below. Bank may enforce each Guarantor's promise without attempting to collect
Borrower's Obligations from Borrower, any co-maker, any other guarantor, or
anyone else who is liable for Borrower's Obligations.

        4. BANK'S RIGHT NOT TO PROCEED AGAINST COLLATERAL. Bank may enforce
Guarantor's promise without attempting to enforce Bank's rights in any
collateral Bank now has or may later acquire as security for Borrower's
Obligations.

        5. OTHER RIGHTS OF BANK AND GUARANTOR'S WAIVER OF NOTICE. Bank may do
any of the following things as many times as Bank wishes, without Guarantor's
permission and without notifying Guarantor, and this will not affect Guarantor's
promise:

                (a) Bank may extend the time for repayment of any of Borrower's
        Obligations.

                (b) Bank may renew any of Borrower's Obligations.

                (c) Bank may stop lending money or extending other credit to
        Borrower.

                (d) Bank may make any other changes in its agreement with
        Borrower.

                (e) Bank may exchange or release any collateral Bank now holds
        or may later acquire as security for Borrower's Obligations.

<PAGE>   2

                (f) Bank may apply any money or collateral received from or on
        behalf of Borrower to the repayment of any of Borrower's Obligations in
        any order Bank wishes.

        6. GUARANTOR'S ADDITIONAL WAIVERS OF NOTICE. Bank does not have to
notify Guarantor of any of the following events and this will not affect
Guarantor's promise:

                (a) Bank does not have to notify Guarantor of Bank's acceptance
        of Guarantor's promise.

                (b) Bank does not have to notify Guarantor when Bank lends
        money, leases equipment or extends other credit to Borrower or acquires
        Obligations of Borrower.

                (c) Bank does not have to notify Guarantor of Borrower's failure
        to pay Borrower's Obligations when due, or of Borrower's failure to
        perform any other duty owed to Bank when required.

Bank will use its reasonable efforts to notify Guarantor of any failure by
Borrower to pay the Obligations when due; provided, however, any reasonable
failure or delay by Bank in doing so shall not affect Guarantor's promise.

        7. GUARANTOR'S DUTY TO KEEP INFORMED OF BORROWER'S FINANCIAL CONDITION.
Guarantor is now adequately informed of Borrower's financial condition, and
Guarantor agrees to keep so informed. Bank does not have to provide Guarantor
with any present or future information concerning the financial condition of
Borrower, and this does not affect Guarantor's promise. Guarantor has not relied
on financial information furnished by Bank.

        8. GUARANTOR'S AGREEMENT TO POSTPONE RIGHTS AGAINST BORROWER. By paying
Bank under this agreement, Guarantor may acquire rights against Borrower such as
subrogation rights. Guarantor agrees not to exercise any of those rights until
Borrower has fully paid its Obligations to Bank.

        9. GUARANTOR'S ASSIGNMENT OF RIGHTS AGAINST BORROWER. Guarantor assigns
to Bank all rights Guarantor may have against Borrower or Borrower's property in
any proceeding under the federal Bankruptcy Code, or any receivership or
insolvency proceeding. This assignment includes all rights of Guarantor to be
paid by Borrower even though they have nothing to do with this agreement.
However, when Bank has been fully paid everything owed under Guarantor's
promise, these rights will automatically be reassigned by Bank to Guarantor,
without any action by either of them, and Guarantor may then enforce any of
these rights which still remain. This assignment does not prevent Bank from
enforcing Guarantor's promise in any way.

        10. ATTORNEY'S FEES AND COLLECTION EXPENSES. Guarantor agrees to pay a
reasonable attorneys' fee and all other reasonable costs and reasonable expenses
which Bank may incur in enforcing or defending this agreement, whether or not a
lawsuit is started.

        11. LAW THAT APPLIES AND WHERE GUARANTOR MAY BE SUED. This agreement is
governed by Washington law. Guarantor consents to the personal jurisdiction of
the courts of the State of Washington and the federal courts located in
Washington so that Bank may sue

                                       2
<PAGE>   3

Guarantor in Washington to enforce this agreement. Guarantor agrees not to claim
that Washington is an inconvenient place for trial. At Bank's option, the venue
(location) of any suit to enforce this agreement may be in Seattle, Washington.

        12.    MANDATORY ARBITRATION.

               (a) At the request of either Bank or Guarantor, any controversy
        or claim between Bank and Guarantor, arising from or relating to this
        agreement, or arising from an alleged tort, shall be settled by
        arbitration in Seattle, Washington. The United States Arbitration Act
        shall apply even though this agreement is otherwise governed by
        Washington law. The proceedings shall be administered by the American
        Arbitration Association under its commercial rules of arbitration. Any
        controversy over whether an issue is arbitrable shall be determined by
        the arbitrator(s). Judgment upon the arbitration award may be entered in
        any court having jurisdiction over the parties. The institution and
        maintenance of an action for judicial relief or pursuit of an ancillary
        or provisional remedy shall not constitute a waiver of the right of
        either party, including the plaintiff, to submit the controversy or
        claim to arbitration if such action for judicial relief is contested.
        For purposes of the application of the statute of limitations, the
        filing of an arbitration pursuant to this subsection is the equivalent
        of the filing of a lawsuit, and any claim or controversy which may be
        arbitrated under this subsection is subject to any applicable statute of
        limitations. The arbitrator(s) will have the authority to decide whether
        any such claim or controversy is barred by the statute of limitations
        and, if so, to dismiss the arbitration on that basis. The parties
        consent to the joinder of any guarantor, hypothecator, or other party
        having an interest relating to the claim or controversy being arbitrated
        in any proceedings under this Section.

               (b) Notwithstanding the provisions of subsection (a), no
        controversy or claim shall be submitted to arbitration without the
        consent of all parties if at the time of the proposed submission, such
        controversy or claim arises from or relates to an obligation secured by
        real property.

               (c) No provision of this subsection shall limit the right of
        Guarantor or Bank to exercise self-help remedies such as set-off,
        foreclosure, retention or sale of any collateral, or obtaining any
        ancillary, provisional, or interim remedies from a court of competent
        jurisdiction before, after, or during the pendency of any arbitration
        proceeding. The exercise of any such remedy does not waive the right of
        either party to request arbitration.

        13. COUNTERPARTS. This agreement may be signed in any number of
counterparts, each of which shall be an original, with the same effect as if the
signatures to such counterparts were upon the same instrument. This agreement
shall become effective as to each Guarantor when a counterpart signed by such
Guarantor is received, regardless of whether all other counterparts are
received.

        14. WHOLE AGREEMENT. This agreement, including all counterparts,
constitutes the entire understanding between Bank and Guarantor concerning the
guaranty reflected by this agreement, and it may be changed only in writing
signed by Bank and Guarantor.

                                       3
<PAGE>   4

        GUARANTOR HAS READ THIS AGREEMENT AND RECEIVED A COPY. BY SIGNING THIS
AGREEMENT, GUARANTOR AGREES TO ITS TERMS. GUARANTOR UNDERSTANDS THAT, AS A
RESULT, GUARANTOR IS LIABLE FOR THE OBLIGATIONS OF BORROWER IF BORROWER FAILS TO
PAY BANK WHEN THEY ARE DUE. IF THIS HAPPENS, BANK MAY, IF IT WANTS, REQUIRE
GUARANTOR TO PAY BORROWER'S OBLIGATIONS.

Dated as of May 9, 2000.

                                            Guarantor:

                                            ILLUMINET HOLDINGS, INC.

                                            /s/  DANIEL E. WEISS
                                            ------------------------------------
                                            By: Daniel E. Weiss
                                            Title: Vice President Finance,
                                            Chief Financial Officer, Treasurer,
                                            and Secretary

                                       4<PAGE>   1
VIII
    D

                                                                   EXHIBIT 10.12

                         PROCESS DEVELOPMENT CONSORTIUM

                              MEMBERSHIP AGREEMENT

     This Agreement is entered into as of February 28, 1999 (the "Effective
Date") by and between Argonaut Technologies, Inc., a Delaware corporation with
its principal place of business at 887 Industrial Road, Suite G, San Carlos,
California 94070 ("Argonaut"), and Eli Lilly and Company, an Indiana
corporation with its principal place of business at Lilly Corporate Center,
Indianapolis, Indiana 46285 ("Member").

     WHEREAS, Argonaut has expertise in the development of instrumentation
utilizing automated organic chemistry for the preparation of small organic
molecules of broad chemical diversity;

     WHEREAS, Argonaut has established a Process Development Consortium ("PDC")
to consist of up to ten (10) members which are from the pharmaceutical,
biotechnology, and chemical industries, and Argonaut, for the purpose of
discussing and identifying desirable features, concepts and designs for
instrumentation for automating process development.

     WHEREAS, the Member wishes to be a member of the PDC, on the terms and
conditions herein.

     NOW THEREFORE, the parties agree as follows:

                               CONCEPT VALIDATION

     Every company who participates in individual meetings regarding the
Process Development Consortium has a high level of interest in the concept and
product. The product to be developed is code named "Process". There was
approval of the overall concept and validation of the primary specifications
and features.

                                 SPECIFICATIONS

     The general specifications for the Process Instrument are listed in
Exhibit A.

                               EXPECTED TIME LINE

     The current expected time line is outlined in Exhibit B.

                             MEMBERSHIP ADVANTAGES

     Member companies will benefit from early exposure to and hands on
experience with prototype instruments, interaction with peers from other
companies and most importantly, input into the design and development process
to ensure the development and commercialization of system for process chemistry
research and development needs.
<PAGE>   2

                              TERMS OF MEMBERSHIP

     Term. The term of the Agreement is from the effective date of this
Agreement to the commercial release date of the Process Instrument.

     Participation. There will be a minimum of seven (7) and a maximum of ten
(10) members in the Consortium.

     Meetings. The Consortium will meet quarterly during the Term at Argonaut's
facilities in San Carlos, California, or another mutually agreed site. In
addition, Argonaut may meet with Member individually, as agreed by Argonaut and
such Member. Each party shall pay its own costs incurred in connection with
such meetings. Argonaut will be responsible for managing the Consortium,
including conducting the quarterly meetings, setting agendas and providing the
format for the discussion and exchange of ideas. Argonaut will bear the cost of
the meeting facilities.

     Prototypes. Members will have an opportunity to use the prototype
instruments and software at Argonaut's San Carlos, CA facility on a scheduled
basis during the Term of this Agreement.

     Fee. In consideration for its participation in the PDC, Member shall pay to
Argonaut, One Hundred and Five Thousand U.S. Dollars ($105,000). The payment is
due and payable within 30 days after execution of this agreement.

     Quest 205 Instrument. Upon signing this Agreement, Argonaut shall ship to
Member one (1) unit of Quest 205 (part number 900144). The title to the Quest
205 Instrument shall pass to the Member FOB Shipping Point. The Member will be
responsible for all applicable taxes, duties, VAT and freight charges.

     Process Instrument. Argonaut shall ship to Member one (1) unit of the
commercial Process Instrument according to Exhibit B. The title to the Process
Instrument shall pass to the Member FOB Shipping Point. The Member will be
responsible for all applicable taxes, duties, VAT and freight charges.

     Failure to Complete Consortium. If Argonaut fails to have at least seven
(7) members join the Consortium by March 31, 1999, Argonaut shall, by April 30,
1999, refund to Member all amounts paid less the price of the Quest 205
Instrument [*].

     Priority. In consideration for its participation in the PDC, and provided
that Member timely pays Argonaut the amounts set forth above, Member will be
entitled to priority status and discount with regard to the purchase of
subsequent commercial "Process" Instruments, not including the original Process
Instrument delivered under this Agreement. To implement priority status and take
advantage of the related discount, a purchase order must be received by June 30,
1999 to receive a [*] discount from the commercial, non-academic regional list
price established by Argonaut (the "List Price"). To implement priority status
and take advantage of the related discount, a purchase order must be received by
September 30, 1999 to receive a [*] discount from the commercial, non-academic
regional list price established by Argonaut (the "List Price"). Shipment
priority among Member and other PDC members will be based on the order of
receipt of purchase orders from Member or such other PDC members.

[*] Confidential Treatment Requested

                                       2
<PAGE>   3
     Confidential Information. In connection with the performance of this
Agreement, Argonaut or Member may not disclose confidential or proprietary
technical or business information to the other. There shall be no
Confidentiality Agreement in force under this Agreement, except for the
financial terms of this Agreement.

     Publicity. In connection with the performance of this Agreement, Argonaut
may use Member names in press release's announcing the formation of the
Consortium and Process Instrument related items.

     Purchase Orders. Lilly shall submit to Argonaut its standard form of
purchase order for the equipment to be delivered hereunder, including, but not
limited to, the Process Instrument and Quest 205 Instrument delivered as a
result of Member joining the Consortium, and, notwithstanding anything in this
agreement to the contrary, the terms of such purchase order shall govern
Member's acquisition of such equipment hereunder.

     IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be
executed by their duly authorized officers.

ELI LILLY AND COMPANY                  ARGONAUT TECHNOLOGIES, INC.

BY: Richard F. Eizenber                BY: Mark W. Schwartz, Ph.D

TITLE: Executive Director              TITLE: Vice President,
                                              Marketing and Business Development

SIGNATURE: /s/ RICHARD F. EIZENBER     SIGNATURE: /s/ MARK W. SCHWARTZ

BY: _______________________________

TITLE: ____________________________

SIGNATURE: ________________________

                                       3
<PAGE>   4
                                   EXHIBIT A

                                      [*]

[*] Confidential Treatment Requested

                                       4
<PAGE>   5

[*]

[*] Confidential Treatment Requested

                                       5
<PAGE>   6
                                   APPENDIX B

                             ARGONAUT TECHNOLOGIES'
                         Process Synthesizer Instrument
                              Consortium Timelines

     The timeline detailed below is the current timeline Argonaut believes is
appropriate for the development of the Process Synthesizer. This timeline is
subject to changes based on input from Consortium members, changes to technical,
instrument or software specifications, or unforeseen technical problems. This
timeline should be taken as an indication of the current expectation and current
goals of the Process Development effort, but by no means the unequivocal
timeline for the development of the product.

<TABLE>
<CAPTION>
<S>  <C>                                                              <C>
1.   Consortium Membership Completed: ............................... March 1999

2.   First Consortium Meeting: ...................................... March 1999
               Features and Specification Review and Justification
               Software Discussion
               Validation Experiments

3.   First Generation Prototype Operational.......................... February 1999

4.   Chemistry Performed: ........................................... February 1999

5.   Second Consortium Meeting: ..................................... May 1999
               Review Prototype
               Review Chemistry
               Prototype Software Design Review
               Prototype Hardware Design Review

6.   Prototype Software Distribution: ............................... July 1999

7.   Advanced Prototype Instrument Operational: ..................... August 1999

8.   Prototype Chemistry: ........................................... September 1999

9.   Third Consortium Meeting: ...................................... September 1999

10.  Manufactured Pre-production Units Assembled: ................... October 1999

11.  Chemistry Validation: .......................................... October 1999

12.  First Commercial Unit Shipments to Consortium Members: ......... December 1999
</TABLE>

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00012-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00012-of-00352.parquet"}]]